CUHK Develops Microrobots To Speed Up Medical Test

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1442669_1_20190213182235.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1442669-20190213.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1442669-20190213.htm', 'DCS.dcsqry', '' ); } } }); }); });

2019-02-13 HKT 18:22

Share this story

facebook

  • Researchers say their new microrobots will drastically cut down the time it takes to check whether patients have a C difficile infection. Photo: RTHK

    Researchers say their new microrobots will drastically cut down the time it takes to check whether patients have a C difficile infection. Photo: RTHK

Experts at Chinese University have developed a new test using microscopic robots that they say can diagnose people suffering from a deadly type of gastrointestinal infection known as Clostridium Difficile, in a fraction of the time that current tests take.

C difficile infections are very common – especially among elderly patients and the chronically ill – and can prove fatal in extreme cases. Patients typically have symptoms such as diarrhoea and fever, and doctors need to identify whether patients are in fact infected with this particular type of bacteria before they can start treatment.

The problem is, patients have to undergo two sets of tests that can take as long as two days – a delay that doctors say is not ideal.

But experts at Chinese University say microrobots smaller than a red blood cell, made from plant spores, can cut that time down to 15 minutes.

The microrobots have carbon dots on them, that are fluorescent. But if they're mixed in with stool samples that contain toxins produced by C difficile, their fluorescence declines.

Professor Joseph Sung from the university's faculty of medicine said this new test isn't just quick, it is more accurate.

"The advantage of this test is that it can skip the two-step approach that we currently use for the diagnosis of C difficile diarrhoea," Sung said.

The Faculty of Engineering's Professor Zhang Li, who developed the microrobots, said they could be used to identify other pathogens in future.

The university said it will conduct more clinical trials this year before deciding when to officially introduce the new test.

RECENT NEWS

OCBC Plans Hong Kong Wealth Expansion With Up To 50 New Bankers

OCBC is expending its wealth management team in Hong Kong by 30% this year to meet growing regional demand for investme... Read more

Hana Financial To Acquire US$669M Stake In Dunamu, Deepening Crypto Push

Hana Financial Group has agreed to acquire a 6.55% stake in digital asset operator Dunamu. The transaction is valued at... Read more

Reap And TerraPay Partner To Expand Cross-Border Payouts Via Local Payment Rails

Reap has partnered with TerraPay to expand its cross-border payout network using domestic clearing systems. The integra... Read more

Tencent Fintech And Cloud Services Lift Q1 2026 Revenue 9% To US$8.68 Billion

Tencent reported a 9% increase in revenue from its fintech and business services division for the first quarter of 2026... Read more

Ant Group Profit Falls An Estimated 79% As AI And Payments Spending Rises

Ant Group saw an estimated 79% decline in quarterly profit as the company accelerates its spending on AI, large languag... Read more

Alibabas Cloud Revenue Jumps 40% As AI Investments Pressure Profitability

Alibaba Group has released its financial results for the quarter and fiscal year ending 31 March 2026, reporting a 3% a... Read more